SCHEMBL11209765

SCHEMBL11209765

C=CC[Sn+3].CC[O-].CC[O-].CC[O-]

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.37
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30763174 0.87 TSHR (0.40) TSHRALDH1A1
SCHEMBL27096646 0.85 TSHR (0.33) TSHRALDH1A1
SCHEMBL27096700 0.78 TSHR (0.48) TSHRALDH1A1
SCHEMBL27096689 0.77 TSHR (0.33) TSHRALDH1A1
SCHEMBL7130290 0.76 TSHR (0.36) TSHRALDH1A1
Water SCHEMBL546029 0.76
SCHEMBL547124 0.76 TSHR (0.36) TSHRALDH1A1
Hydrogen Sulfide SCHEMBL2496132 0.76
SCHEMBL27096661 0.76
Hydrochloric Acid SCHEMBL18979664 0.72 TSHR (0.33) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250257082-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-14 US disclosed
EP-4568977-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF GELEST, INC. (US) 2025-06-18 EP disclosed
US-12060377-B2 High purity tin compounds containing unsaturated substituent and method for preparation thereof GELEST, INC. (US) 2024-08-13 US disclosed
US-20240158422-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF MITSUBISHI CHEMICAL CORPORATION (JP) 2024-05-16 US disclosed
US-20240059716-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF MITSUBISHI CHEMICAL CORPORATION (JP) 2024-02-22 US disclosed
US-20240059717-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF GELEST, INC. 2024-02-22 US disclosed
WO-2024035914-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF GELEST, INC. (US) 2024-02-15 WO disclosed
US-4370028-A Method of producing liquid crystal display devices with alignment layer formed from organic tin compound of the type Rn SnX4-n SIEMENS AKTIENGESELLSCHAFT (DE) 1983-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12060377-B2 High purity tin compounds containing unsaturated substituent and method for preparation thereof SNX9, SNX3, IPO9 TSHR 1126/4885ALDH1A1 3580/4885
US-20240059717-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF SNX9, SNX3, IPO9 TSHR 1126/4885ALDH1A1 3580/4885
US-20240158422-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF SNX9, SNX3, IPO9 TSHR 1126/4885ALDH1A1 3580/4885
US-20250257082-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF SNX9, SNX3, IPO9 TSHR 1126/4885ALDH1A1 3580/4885
US-20240059716-A1 HIGH PURITY TIN COMPOUNDS CONTAINING UNSATURATED SUBSTITUENT AND METHOD FOR PREPARATION THEREOF SNX9, SNX3, IPO9 TSHR 1126/4885ALDH1A1 3580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.